Bifidobacterium infantis for Infant Health: Underweight Prevention & More
Explore evidence on Bifidobacterium infantis for preventing underweight in preterm infants, based on a 2026 RCT. The conversation reviews 10 studied health outcomes including reduced diarrhea, necrotising enterocolitis, and respiratory infections, with most showing beneficial effects. Relevant for infant probiotic research.
Can Bifidobacterium infantis help prevent underweight in babies, and is there evidence it works for other health issues too?
Bifidobacterium infantis in Infants
Can it help prevent underweight?
Yes, there is emerging evidence that Bifidobacterium infantis may help reduce the risk of underweight in preterm infants. A 2026 randomized controlled trial (n=244) investigated probiotic intervention in preterm infants and found that supplementation was linked to a lower proportion of abnormal growth outcomes — including weight less than 2 standard deviations below WHO standards at 12 months corrected age1.
The study showed a beneficial, small, statistically significant effect on this outcome1.
Evidence for other health issues
Pillser's research database catalogs 10 health outcomes studied in connection with Bifidobacterium infantis, mostly with promising results:
Health Outcome Studies Beneficial Reduced Diarrhea Incidence 2 studies 1 beneficial, 1 neutral2 Reduced Necrotising Enterocolitis 1 study 1 beneficial3 Reduced Incidence of Late-Onset Sepsis 1 study 1 beneficial4 Reduced Respiratory Infections 1 study 1 beneficial5 Reduced Gastrointestinal Inflammation 1 study 1 beneficial6 Improved Gut Microbiota Balance 1 study 1 beneficial7 Enhanced Disease Resistance 1 study 1 beneficial8 Improved Stability of Gut Microbiota 1 study 1 beneficial9 No Reduction in Antibiotic-Resistant Organism Colonization 1 study 1 beneficial10 Reduced C-Reactive Protein Levels 1 study 0 beneficial (neutral)11 Summary
Overall, Bifidobacterium infantis shows a strong profile of beneficial effects across multiple health outcomes relevant to infant health. The most robustly studied area appears to be reduced diarrhea incidence (2 studies), while the remaining outcomes each have 1 study, all showing beneficial effects except for C-reactive protein reduction (neutral). The research is particularly relevant for preterm infants, where the probiotic appears to support healthy weight gain and reduce the risk of serious conditions like necrotising enterocolitis and late-onset sepsis.
You can find more details on the full Bifidobacterium infantis research page.
⚠️ Always consult a pediatrician before introducing any probiotic to an infant, especially a preterm or low-birth-weight baby.
Footnotes
-
Pillser research database, Bifidobacterium infantis and Reduced Underweight. ↩ ↩2
-
Pillser research database, Bifidobacterium infantis and Reduced Diarrhea Incidence. ↩
-
Pillser research database, Bifidobacterium infantis and Reduced Necrotising Enterocolitis. ↩
-
Pillser research database, Bifidobacterium infantis and Reduced Incidence of Late-Onset Sepsis. ↩
-
Pillser research database, Bifidobacterium infantis and Reduced Respiratory Infections. ↩
-
Pillser research database, Bifidobacterium infantis and Reduced Gastrointestinal Inflammation. ↩
-
Pillser research database, Bifidobacterium infantis and Improved Gut Microbiota Balance. ↩
-
Pillser research database, Bifidobacterium infantis and Enhanced Disease Resistance. ↩
-
Pillser research database, Bifidobacterium infantis and Improved Stability of Gut Microbiota. ↩
-
Pillser research database, Bifidobacterium infantis and No Reduction in Antibiotic-Resistant Organism Colonization. ↩
-
Pillser research database, Bifidobacterium infantis and Reduced C-Reactive Protein Levels. ↩
-